The CMS Oncology Care Model (OCM) was associated with reduced chemotherapy initiation and lower Medicare spending among ...
A JAMA Internal Medicine study found the CMS Oncology Care Model reduced chemotherapy initiation and Medicare spending in poor-prognosis cancers. The model showed a 1.5 percentage point drop in ...
The BALAD score had good prognostic ability for predicting OS and PFS in patients with advanced uHCC who underwent systemic therapies and was associated with treatment response. Application of the ...
Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results